Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kazia Therapeutics (KZIA) Property, Plant & Equipment (Net) (2009 - 2018)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 64,489.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.32 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.61 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.27 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 518.26 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 73.89
Dec 31, 2018 73.89
Jun 30, 2018 757.04
Jun 30, 2018 757.04
Dec 31, 2017 12,238.48
Dec 31, 2017 12,238.48
Jun 30, 2017 368,093.06
Jun 30, 2017 368,093.06
Dec 31, 2016 110,424.82
Dec 31, 2016 110,424.82
Jun 30, 2016 442,047.83
Jun 30, 2016 442,047.83
Jun 30, 2012 27,284.41
Jun 30, 2012 27,284.41
Dec 31, 2011 20,221.00
Dec 31, 2011 20,221.00
Jun 30, 2011 71,132.81
Jun 30, 2011 71,132.81
Dec 31, 2010 153,079.17
Dec 31, 2010 153,079.17
Jun 30, 2010 152,054.24
Jun 30, 2010 152,054.24
Dec 31, 2009 299,045.24
Dec 31, 2009 299,045.24
Jun 30, 2009 267,908.35
Jun 30, 2009 267,908.35